DFX Intelligence
Borrowers
1,057 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Start from
1,057 borrower groups match
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| Maze Therapeutics, Inc Life sciences | unattributed | 1 | at least $28.0M | 101c | n/a | Feb 1, 2031 | Dec 31, 2025 |
| Sight Sciences, Inc Life sciences | unattributed | 1 | at least $28.0M | 100c | n/a | Jul 1, 2028 | Mar 31, 2024 |
| Redwood MSO LLC Healthcare services | unattributed | 4 | at least $27.9M | 101c | 2 pts | Dec 20, 2029 | Dec 31, 2024 |
| P•••••• C••• D••••• M••••••••• L•• Healthcare services | Sponsor not establishedpossible: T•• L• (a company of this name is on the sponsor's portfolio page) | 4 | at least $27.9M | 100c | n/a | Aug 31, 2028 | Dec 31, 2022 |
| N•••••• Life sciences · grade B | unattributed | 1 | at least $27.6M | 100c | n/a | Nov 1, 2026 | Dec 31, 2022 |
| u•••••• B•• Life sciences · grade B | unattributed | 1 | at least $27.5M | 103c | n/a | Oct 1, 2030 | Dec 31, 2022 |
| M••••••• L•• Healthcare services | unattributed | 7 | at least $27.4M | 100c | 1 pts | Oct 20, 2029 | Dec 31, 2023 |
| K•••• H••••• L•• Healthcare services | unattributed | 6 | at least $27.3M | 98c | 7 pts | Apr 27, 2028 | Dec 31, 2021 |
| E••• P••••••••• I•• Life sciences | unattributed | 1 | at least $27.0M | 106c | n/a | Dec 17, 2027 | Jun 30, 2026 |
| P•••• Q•••• A••••••••• L•• Healthcare services | unattributed | 3 | at least $27.0M | 100c | 0 pts | Nov 13, 2031 | Mar 31, 2023 |
| M•••• A••••••••• I•• Healthcare services | unattributed | 5 | at least $26.8M | 101c | 1 pts | Mar 1, 2029 | Mar 31, 2023 |
| N•• W••• P•••••• L•• Healthcare services | unattributed | 4 | at least $26.7M | 112c | n/a | May 9, 2030 | Dec 31, 2024 |
| H••••••• I••••••••• L•• E•• Life sciences | unattributed | 1 | at least $26.6M | n/a | n/a | Sep 9, 2032 | Sep 30, 2025 |
| S•• D••••• P••••••• O•••• L•• Healthcare services | Sponsor not establishedpossible: T••••••• A••••••• (a company of this name is on the sponsor's portfolio page) | 3 | at least $26.4M | 102c | n/a | Jun 13, 2031 | Sep 30, 2024 |
| N••••••• D••••• C••• Healthcare services | unattributed | 1 | at least $26.4M | 45c | n/a | Jul 31, 2026 | Dec 31, 2022 |
| D•• M••••••••• L•• Healthcare services | unattributed | 2 | at least $26.3M | 98c | n/a | Dec 18, 2027 | Dec 31, 2024 |
| P•• P•••• P•• M••••• T•••• L•• Life sciences | unattributed | 1 | at least $26.3M | 98c | n/a | Feb 13, 2032 | Dec 31, 2025 |
| B•••••• O•••• L•• Life sciences | unattributed | 1 | at least $25.9M | 100c | n/a | May 31, 2027 | Jun 30, 2023 |
| M•••••• B••••••••• T••••••• L•• Healthcare services | unattributed | 3 | at least $25.9M | 101c | 0 pts | Jun 6, 2030 | Jun 30, 2024 |
| L••• S•••••• C••••• C•••• B••••••••• Life sciences | unattributed | 1 | at least $25.5M | 100c | n/a | Mar 1, 2028 | Dec 31, 2024 |
| R•••••• F••••• C••• N••••••• I•• Healthcare services | unattributed | 2 | at least $25.4M | 101c | 0 pts | Jun 19, 2028 | Dec 31, 2022 |
| P••••••••• H••••• H•••••••• I•• Life sciences | unattributed | 9 | at least $25.3M | 99c | 1 pts | Mar 19, 2032 | Dec 31, 2021 |
| W••••••••• L•• Healthcare services | unattributed | 2 | at least $25.1M | 100c | 0 pts | Dec 31, 2027 | Mar 31, 2022 |
| C••••••• S••••• L•• Life sciences | Sponsor not establishedpossible: B••••• W••• C••••••• L•• (a company of this name is on the sponsor's portfolio page) | 3 | at least $25.1M | 103c | n/a | Mar 31, 2030 | Mar 31, 2025 |
| T••••• M•••••• C•••••••• I•• Life sciences | unattributed | 5 | at least $25.1M | 100c | n/a | Jan 31, 2031 | Dec 31, 2022 |
| M•• V•• B•••••••• L•• Healthcare services | unattributed | 2 | at least $25.0M | 101c | 0 pts | Jan 3, 2029 | Dec 31, 2024 |
| J•••••• M•••••• C••••••••• Life sciences | unattributed | 1 | at least $25.0M | 106c | n/a | Jun 27, 2028 | Jun 30, 2026 |
| M•••••••• S••••••• I•• Healthcare services · Life sciences | unattributed | 1 | at least $25.0M | 106c | n/a | Aug 18, 2028 | Jun 30, 2026 |
| S••••• T••••••••• P•• Life sciences | unattributed | 1 | at least $25.0M | 104c | n/a | Sep 28, 2028 | Dec 31, 2025 |
| 4• N•••• D•••••• L•• Healthcare services | unattributed | 1 | at least $24.7M | 100c | n/a | Feb 10, 2031 | Mar 31, 2026 |
| H••••••••• Life sciences | unattributed | 1 | at least $24.7M | 100c | n/a | Apr 10, 2034 | Jun 30, 2026 |
| H••••••••• H••••••• T••••••••• I•• Healthcare services | unattributed | 1 | at least $24.1M | 63c | n/a | Aug 1, 2029 | Dec 31, 2024 |
| S••••• A••••••••• L•• Life sciences | unattributed | 2 | at least $23.9M | 101c | 0 pts | Feb 2, 2033 | Mar 31, 2026 |
| U••• H••••• L•• Life sciences | unattributed | 2 | at least $23.8M | 99c | 1 pts | May 26, 2031 | Jun 30, 2025 |
| P•••••• D••••• P••••••• C•••••• L•• Life sciences | unattributed | 2 | at least $23.4M | 101c | n/a | Jan 31, 2031 | Mar 31, 2025 |
| A•••••• T••••••••• I•• Life sciences | A•••••••• C•••••• P••••••• inferred | 6 | at least $22.9M | 59c | 0 pts | Dec 31, 2028 | Dec 31, 2021 |
| M•••• N••••••• P••••••• S•••••• L•• Healthcare services | unattributed | 1 | at least $22.8M | 101c | n/a | Mar 1, 2029 | Dec 31, 2024 |
| B••••••••• F•••••••• L•• Healthcare services | Sponsor not establishedpossible: R•••••• A••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 2 | at least $22.5M | 101c | n/a | Nov 20, 2031 | Dec 31, 2025 |
| N•• T•• H••••••• C••• Life sciences | Sponsor not establishedpossible: C•••• S••••• C•••••• (a company of this name is on the sponsor's portfolio page) | 5 | at least $22.4M | 100c | 1 pts | May 1, 2029 | Dec 31, 2023 |
| A•••••• P••••• U•• I•• Life sciences | unattributed | 6 | at least $22.3M | 99c | n/a | Nov 30, 2028 | Dec 31, 2021 |
| H••••••• D••••• H•••••• L•• Healthcare services | unattributed | 4 | at least $22.3M | 100c | 0 pts | Jun 13, 2028 | Jun 30, 2023 |
| U• W•••••••• V•••••••• L•• Life sciences | unattributed | 1 | at least $22.0M | 99c | n/a | Jul 31, 2030 | Sep 30, 2024 |
| B••• O••••••••• B••••• I•• Healthcare services | unattributed | 2 | at least $22.0M | 102c | n/a | Apr 30, 2035 | Dec 31, 2021 |
| S••••• R••••••••• L•• Life sciences | unattributed | 2 | at least $21.9M | 72c | n/a | Dec 29, 2028 | Dec 31, 2022 |
| A••••••• M•••••• M••••••••• L•• Healthcare services | unattributed | 2 | at least $21.8M | 100c | n/a | Dec 18, 2026 | Dec 31, 2024 |
| H•••••• H•• U• H••••••• I•• Healthcare services | unattributed | 2 | at least $21.8M | 101c | n/a | Dec 3, 2030 | Dec 31, 2024 |
| H••••••••• H•••••••• L•• Healthcare services | I••••••• C•••••• P•••••••• L•• inferred | 5 | at least $21.7M | 100c | 1 pts | Dec 15, 2028 | Dec 31, 2022 |
| T•••• M•••••• L•• Education | unattributed | 3 | at least $21.7M | 100c | n/a | Jun 12, 2031 | Jun 30, 2025 |
| Q•••• A•••••••• I•• Healthcare services | unattributed | 2 | at least $21.7M | 99c | 0 pts | Nov 10, 2032 | Dec 31, 2025 |
| F•••• M•••••• M••• L•• Education | unattributed | 2 | at least $21.5M | 97c | n/a | Jun 13, 2027 | Sep 30, 2025 |
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.